Biotech

All Articles

Repare gives up 25% of workers as biotech stops preclinical R&ampD

.Repare Therapy is giving up a quarter of its own workforce as the oncology biotech downsize its own...

J &amp J apply for FDA permission of $6.5 B autoimmune medicine

.Johnson &amp Johnson has actually taken an additional action towards realizing a yield on its $6.5 ...

Gain's phase 1 gain paves technique to prove Parkinson's medication's worth

.Increase Therapeutics has actually specified its sights on showing the effectiveness of its own Par...

Actinogen documents brand new phase 2 information to save depression medication

.Actinogen Medical's chances-- as well as stock rate-- have rebounded somewhat coming from previousl...

Pfizer and also Main add Quotient to multibillion-dollar formula

.Crown Jewel Pioneering and also Pfizer have included Quotient into their 10-program collaboration, ...

Bayer markers $547M deal to drive boundaries of noncoding RNA

.Bayer execs were actually interested to tension to Brutal this summertime that the German pharma ti...

UK unveils strategies to launch 18 new clinical test hubs

.In the middle of a yearslong clinical test decline in the U.K., a brand new public-private partners...

UPDATE: Genentech telegraphs 93 unemployments in California after sharing programs to shutter cancer cells immunology investigation system

.Observing the news of a large discharge shot in April and also a significant rebuilding initiative ...

Neurocrine's KarXT opponent reaches in stage 2-- but just at reduced dose

.Neurocrine Biosciences has achieved its hoped-for profile in a period 2 schizophrenia trial, delive...

Vaderis' rare blood vessel problem medicine minimizes nosebleeds

.Vaderis Rehabs' objective to build the very first medication targeted specifically at a certain unu...